Grifols announces inclusion on the Bloomberg Gender-Equality Index, recognizing commitment to gender equity; 60% of Grifols' team is made up of women, with a target for 50% of senior management made up of women by 2030

BARCELONA , January 26, 2022 (press release) –

• For the second consecutive year, Grifols is part of the Bloomberg Gender-Equality Index (GEI), reaffirming its commitment to equality, female leadership and talent promotion.
• Currently, 60% of Grifols’ human team is made up of women.
• The company’s goal is to have 50% of its senior management made up of women by 2030.
• Grifols is also part of the Dow Jones Sustainability World Index (DJSI), Vigeo Euronext and FTSE4Good.

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines with a proven track record of more than 110 years contributing to people’s health and well-being, has been included, for the second consecutive year in 2022, in the “Bloomberg Gender-Equality Index” (GEI).

Grifols reaffirms its commitment to the advancement of women in the labor market through policies that promote women’s professional careers and a greater female representation in the organization. Currently, 60% of employees are women, who in 98% of cases have permanent contracts.

Being a part of this index reflects Grifols’ constant involvement with equality, gender diversity and fundamental human rights, as well as its vocation, for more than a hundred years, to promote the talent and full potential of its employees in an equal, inclusive and non-discriminatory way.

Within the framework of this commitment, Grifols launched a Diversity and Inclusion Plan in 2021 aimed at continuing to bolster progress and being another catalyst for improvement in this area, positioning the company as a reference for diversity and inclusion. The company’s goal for 2030 is to have 50% of its senior management made up of women.

For Montse Gaja, Chief of Human Resources at Grifols: “Continuing to be a part of this index is a source of pride. It reflects our commitment to continue being a reference in equality and diversity, as well as our efforts to foster an inclusive culture in which women feel empowered, qualified and are visible in the organization. True to our values, we will remain committed to advancing these fundamental principles, always placing our team as a priority”.

In addition, being a part of GEI reaffirms Grifols’ efforts of continue contributing to the achievement of the Sustainable Development Goals (SDGs) promoted by the United Nations, specifically SDG 5 that refers to achieving gender equality and the empowerment of women, which the company promotes in its strategy and integrates into its Sustainability Master Plan.

A useful evaluation tool for investors

The Bloomberg Gender-Equality index provides transparency over the practices and policies related to gender equality and diversity in publicly-listed companies. This comprehensive information available in regards to the environmental, social and corporate governance (ESG) criteria, allows investors to benchmark companies’ performance.

In its elaboration, a total of 70 metrics grouped in five pillars are analyzed: female leadership and talent promotion; equal pay and gender pay parity; inclusive culture; sexual harassment policies and pro-women campaigns.

Since December 2021, Grifols is part of the Dow Jones Sustainability World Index (DJSI). In 2020, the company became part of the DJSI Europe, Euronext Vigeo Europe 120 and the Euronext Vigeo Eurozone 120, and since 2018, it is also a member of the FTSE4Good Global, FTSE4Good Europe and FTSE4Good Ibex sustainability stock market indices.

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed to, promoting any products in countries in which they are not approved.